A carregar...
Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making
The controversy surrounding the use of hydroxychloroquine (HCQ), an antimalarial drug, for COVID-19 has raised numerous ethical and policy problems. Since the suggestion that HCQ has potential for COVID-19, there have been varying responses from clinicians and healthcare institutions, ranging from a...
Na minha lista:
| Publicado no: | J Med Ethics |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7371492/ https://ncbi.nlm.nih.gov/pubmed/32647045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/medethics-2020-106306 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|